ReviewFrontiers in immunology2020

Manufacturing and Management of CAR T-Cell Therapy in "COVID-19's Time": Central Versus Point of Care Proposals.

Iñaki Ortiz de Landazuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.